$13.55 Billion in Sales Expected for HCA Healthcare, Inc. (NYSE:HCA) This Quarter

Equities analysts expect HCA Healthcare, Inc. (NYSE:HCA) to post sales of $13.55 billion for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have issued estimates for HCA Healthcare’s earnings, with estimates ranging from $12.84 billion to $13.87 billion. HCA Healthcare reported sales of $11.07 billion in the same quarter last year, which would suggest a positive year over year growth rate of 22.4%. The company is scheduled to report its next earnings report on Wednesday, July 28th.

According to Zacks, analysts expect that HCA Healthcare will report full year sales of $55.32 billion for the current year, with estimates ranging from $54.75 billion to $56.22 billion. For the next year, analysts expect that the business will post sales of $58.25 billion, with estimates ranging from $57.41 billion to $58.90 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side analysts that that provide coverage for HCA Healthcare.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Thursday, April 22nd. The company reported $4.14 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.35 by $0.79. The business had revenue of $13.98 billion during the quarter, compared to analysts’ expectations of $13.58 billion. HCA Healthcare had a return on equity of 2,032.72% and a net margin of 6.70%. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.33 EPS.

A number of brokerages have recently commented on HCA. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell began coverage on HCA Healthcare in a report on Thursday. They set a “neutral” rating and a $215.00 price target for the company. Truist upped their price target on HCA Healthcare from $200.00 to $230.00 in a report on Wednesday, April 14th. Oppenheimer upped their target price on HCA Healthcare from $200.00 to $230.00 and gave the company an “outperform” rating in a research note on Friday, April 23rd. Truist Securities upped their target price on HCA Healthcare from $200.00 to $230.00 and gave the company a “buy” rating in a research note on Tuesday, April 20th. Finally, Barclays upped their target price on HCA Healthcare from $195.00 to $225.00 and gave the company an “overweight” rating in a research note on Friday, April 23rd. They noted that the move was a valuation call. One research analyst has rated the stock with a sell rating, three have issued a hold rating and fifteen have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $200.10.

In other news, SVP Robert A. Waterman sold 73,853 shares of the firm’s stock in a transaction dated Wednesday, February 24th. The stock was sold at an average price of $176.75, for a total transaction of $13,053,517.75. Following the sale, the senior vice president now owns 339,205 shares of the company’s stock, valued at $59,954,483.75. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, SVP Deborah M. Reiner sold 3,432 shares of the firm’s stock in a transaction dated Tuesday, May 11th. The stock was sold at an average price of $208.33, for a total value of $714,988.56. Following the sale, the senior vice president now directly owns 6,576 shares in the company, valued at approximately $1,369,978.08. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 432,085 shares of company stock worth $84,791,254. Company insiders own 1.80% of the company’s stock.

A number of institutional investors have recently made changes to their positions in HCA. Thompson Siegel & Walmsley LLC acquired a new stake in HCA Healthcare in the 4th quarter valued at approximately $25,000. Seven Springs Wealth Group LLC acquired a new stake in HCA Healthcare in the 1st quarter valued at approximately $28,000. Safeguard Investment Advisory Group LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth approximately $30,000. Phoenix Wealth Advisors acquired a new position in shares of HCA Healthcare during the 4th quarter worth approximately $32,000. Finally, Perigon Wealth Management LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth approximately $33,000. 68.69% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare stock traded up $4.03 during trading hours on Thursday, reaching $211.50. 1,234,611 shares of the company were exchanged, compared to its average volume of 1,549,448. HCA Healthcare has a 12 month low of $91.21 and a 12 month high of $217.28. The firm has a market cap of $69.93 billion, a price-to-earnings ratio of 21.39, a PEG ratio of 1.28 and a beta of 1.58. The stock has a 50-day moving average of $196.68 and a 200 day moving average of $172.59. The company has a current ratio of 1.13, a quick ratio of 1.00 and a debt-to-equity ratio of 23.70.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 30th. Shareholders of record on Wednesday, June 16th will be issued a dividend of $0.48 per share. This represents a $1.92 dividend on an annualized basis and a yield of 0.91%. The ex-dividend date is Tuesday, June 15th. HCA Healthcare’s dividend payout ratio (DPR) is currently 18.29%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, operates as a health care services company in the United States. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Article: How to read a candlestick chart

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.